Another consideration is that the effect on disease progression was pretty ... Two-year data from a phase 3 trial of exenatide in Parkinson’s is due later this year and could help answer that ...

This randomized controlled trial aimed to assess whether the GLP-1 receptor agonist, exenatide, could slow disease progression in patients with Parkinson’s disease. The primary outcome of this study ...

1. There was no significant difference in functional outcome between both groups at 96 weeks. 2. Exenatide was safe and ...

Other cone snail compounds are being studied to treat epilepsy, Alzheimer’s, and Parkinson’s disease. The snail’s ability to ... the basis for the development of a medication called exenatide (Byetta) ...

Parkinson’s disease lacks a conclusive test, so it is generally diagnosed by assessing symptoms. But now, scientists have shown that AI models can identify signs of the condition in a person’s ...

Stem cell therapy shows early promise for treating Parkinson's. Discover who is in the race to bring this breakthrough to ...

Eating about a dozen servings of ultraprocessed food each day could more than double your risk of developing Parkinson's disease, according to a new study.Video above: Parkinson's patient thanks ...

People who eat more ultra processed foods like cold breakfast cereal, cookies and hot dogs are more likely to have early signs of Parkinson's disease when compared to those who eat very few ultra ...

Recent research has found a link between golf courses and greater odds of developing Parkinson’s disease. Researchers at the Mayo Clinic and others conducted the study, published this month in ...

"Our research shows that eating too much processed food, like sugary sodas and packaged snacks, might be speeding up early signs of Parkinson's disease," said senior study author Dr. Xiang Gao ...

Parkinson's disease (PD) is a disabling neurodegenerative disease that affects approximately 10 million people worldwide, ...